Acceleron Pharma reported $-70630000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Akebia Therapeutics AKBA:US $ -54.89M 24.46M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Amgen AMGN:US $ 2378M 1550M
Arena Pharmaceuticals ARNA:US $ -194.48M 50.09M
Bayer BAYN:GR 530M 2.81B
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Bluebird Bio BLUE:US $ -216.95M 23.88M
Clovis Oncology CLVS:US $ -57.46M 0.12M
Dicerna Pharmaceuticals DRNA:US $ -20.27M 19.97M
Eli Lilly And LLY:US $ 1476M 72.6M
Exelixis EXEL:US $ 51.62M 71.39M
Gilead Sciences GILD:US $ 3842M 1596M
GlaxoSmithKline GSK:LN 1.94B 263M
Johnson & Johnson JNJ:US $ 3849M 2813M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Novartis NOVN:VX 3.23B 246M
Pfizer PFE:US $ 7647M 1733M
Ptc Therapeutics PTCT:US $ -93.08M 5.42M
Puma Biotechnology PBYI:US $ -41.6M 39.87M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Rigel Pharmaceuticals RIGL:US $ -19.78M 6.74M
Sangamo Biosciences SGMO:US $ -48.44M 0.26M
Tg Therapeutics TGTX:US $ -85.13M 7.64M
Ultragenyx Pharmaceutical RARE:US $ -89.83M 7.05M
United Therapeutics UTHR:US $ 228.7M 8.8M
Vertex Pharmaceuticals VRTX:US $ 1054.51M 1092.47M